ESHO Empresa de Serviços Hospitalares S.A/ Hospital Samaritano de Higienópolis

São Paulo 01232-010

1 studies enrolling now · 3 studies all time

What they study most

Multiple Myeloma, Sickle Cell Disease

Studies at this site

• MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) — Recruiting now
• Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant — Running, not enrolling
• Expanded Access Protocol for Adults and Pediatric Patients With Sickle Cell Disease Who Have No Alternative Treatment Options — NO_LONGER_AVAILABLE